LAUREN DAUZAT: Open Payments
NPI 1114694304 · PORT BARRE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 28 payments from 13 companies in 2025. Trend: 2023 $299 · 2024 $944 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| ABBVIE INC. | 3 | $52 |
| Viatris Specialty LLC | 3 | $51 |
| Novo Nordisk Inc | 3 | $49 |
| Astellas Pharma US Inc | 2 | $41 |
| Corcept Therapeutics | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $24 |
Products named: MOUNJARO, CAPLYTA, Auvelity, VRAYLAR, YUPELRI, Ozempic, Veozah, Korlym.
Industry payments across LA — which companies pay providers there.
